
    
      Subjects will be contacted (phone script attached) to inform them of the study and the
      imaging modality. The first 10 patients that agree to participate in the study will be asked
      to present to the Mayo Clinic where they can provide a written consent and perform the
      imaging study.

      Enrolled subjects will be evaluated in the clinical practice prior to having 68Ga-DOTATATE
      PET/CT imaging performed. The treating endocrinologist will be informed of the imaging
      results and will review the results with the subject using a follow-up visit or phone call;
      when a tumor is localized, the endocrinologist will discuss appropriate management options.

      Subjects will be follow for one year post 68Ga-DOTATATE PET/CT.
    
  